Exosomal MiR-92a-3p serves as a Promising Diagnostic Marker and Potential Therapeutic Target for Adenomyosis

In: Research Square · 2024 · doi:10.21203/rs.3.rs-3961335/v1 · W4393988857
preprint OA: green CC0
AI-generated summary by claude@2026-06+body, 2026-06-12

Exosomal miR-92a-3p is upregulated in adenomyosis, promoting cell migration and invasion, and its urinary levels correlate with symptoms, indicating diagnostic and therapeutic potential.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-12 · read from full text

The preprint investigated the role of microRNA miR-92a-3p in adenomyosis by examining miR-92a-3p packaged in exosomes derived from ectopic adenomyosis lesions and assessing effects on eutopic endometrial cells, DRG neurons, and HUVECs, alongside its potential as a urinary exosome biomarker. The study found miR-92a-3p was significantly upregulated in exosomes from ectopic lesions, and that this was associated with enhanced migration and invasion in the tested cell and neuron/endothelial models. It also reported a significant correlation between urinary-exosome miR-92a-3p levels and adenomyosis clinical symptoms, positioning miR-92a-3p as a non-invasive diagnostic marker, while noting the work is a preprint that has not yet undergone peer review. This paper is centrally about endometriosis and/or adenomyosis—specifically adenomyosis—through the diagnostic and mechanistic role of exosomal miR-92a-3p.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 15,288 characters · extracted from preprint-html · click to expand
Exosomal MiR-92a-3p serves as a Promising Diagnostic Marker and Potential Therapeutic Target for Adenomyosis | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Exosomal MiR-92a-3p serves as a Promising Diagnostic Marker and Potential Therapeutic Target for Adenomyosis Wanqi Shao, Yayuan Yu, Jianzhang Wang, Zhiruo Qiu, Shuyan Mei, and 5 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-3961335/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 22 Mar, 2025 Read the published version in Scientific Reports → Version 1 posted 8 You are reading this latest preprint version Abstract This study aimed to elucidate the role of microRNA miR-92a-3p in the pathogenesis of adenomyosis. We focused on understanding how miR-92a-3p in exosomes derived from ectopic lesions influences the behavior of endometrial cells, DRG neurons, and Human Umbilical Vein Endothelial Cells (HUVECs), and its potential as a non-invasive diagnostic biomarker. Our findings revealed that MiR-92a-3p is significantly upregulated in exosomes derived from ectopic lesions of adenomyosis. This upregulation was associated with enhanced migration and invasion capabilities in eutopic endometrial cells, DRG neurons, and HUVECs. Furthermore, the study demonstrated a significant correlation between the levels of MiR-92a-3p in urinary exosomes and the clinical symptoms of adenomyosis, suggesting its potential as a non-invasive biomarker for the disease. This study elucidates an exosomal signaling process via miR-92a-3p that drives pathological infiltration and angiogenesis to promote adenomyosis progression. Upregulated miR-92a-3p in biofluid exosomes shows promising non-invasive biomarker potential for diagnosis and monitoring of this disease. Our findings unveil novel targets and tools for improved clinical management.Our research uncovers the significant role of miR-92a-3p in adenomyosis pathogenesis. We demonstrate that miR-92a-3p, upregulated in exosomes from ectopic lesions, enhances migration and invasion of endometrial cells, DRG neurons, and HUVECs. Crucially, miR-92a-3p levels in urinary exosomes correlate with adenomyosis symptoms, highlighting its potential as a non-invasive biomarker. This study offers new insights into adenomyosis progression and introduces novel diagnostic and therapeutic avenues. Biological sciences/Cell biology Health sciences/Biomarkers Health sciences/Diseases Health sciences/Pathogenesis Full Text Additional Declarations No competing interests reported. Cite Share Download PDF Status: Published Journal Publication published 22 Mar, 2025 Read the published version in Scientific Reports → Version 1 posted Editorial decision: Revision requested 24 Jul, 2024 Reviews received at journal 03 May, 2024 Reviewers agreed at journal 22 Apr, 2024 Reviewers invited by journal 22 Apr, 2024 Editor assigned by journal 22 Apr, 2024 Editor invited by journal 02 Apr, 2024 Submission checks completed at journal 02 Apr, 2024 First submitted to journal 16 Feb, 2024 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-3961335","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":286648255,"identity":"da01edd4-8da0-443d-a67d-51e9bc3cf779","order_by":0,"name":"Wanqi Shao","email":"","orcid":"","institution":"Zhejiang Chinese Medical University","correspondingAuthor":false,"prefix":"","firstName":"Wanqi","middleName":"","lastName":"Shao","suffix":""},{"id":286648256,"identity":"164676a4-7fd1-4e45-87de-05f410bcbb58","order_by":1,"name":"Yayuan Yu","email":"","orcid":"","institution":"Jiaxing University Affiliated Maternity and Child Hospital","correspondingAuthor":false,"prefix":"","firstName":"Yayuan","middleName":"","lastName":"Yu","suffix":""},{"id":286648257,"identity":"fc0b345f-7b70-42d0-a12f-17dc72b9bc7b","order_by":2,"name":"Jianzhang Wang","email":"","orcid":"","institution":"Zhejiang University","correspondingAuthor":false,"prefix":"","firstName":"Jianzhang","middleName":"","lastName":"Wang","suffix":""},{"id":286648258,"identity":"e9ca617c-5c14-4926-bc4f-b3541d4b382f","order_by":3,"name":"Zhiruo Qiu","email":"","orcid":"","institution":"Wenzhou Medical University","correspondingAuthor":false,"prefix":"","firstName":"Zhiruo","middleName":"","lastName":"Qiu","suffix":""},{"id":286648260,"identity":"2c2ae6a7-47b6-4d64-bc70-eb3e982440fd","order_by":4,"name":"Shuyan Mei","email":"","orcid":"","institution":"Wenzhou Medical University","correspondingAuthor":false,"prefix":"","firstName":"Shuyan","middleName":"","lastName":"Mei","suffix":""},{"id":286648262,"identity":"cecc29c6-8572-4f6b-823d-d4eec404ad5e","order_by":5,"name":"Tao Cheng","email":"","orcid":"","institution":"Wenzhou Medical University","correspondingAuthor":false,"prefix":"","firstName":"Tao","middleName":"","lastName":"Cheng","suffix":""},{"id":286648264,"identity":"aeefa100-846f-47ec-85cf-a866a7ccd58b","order_by":6,"name":"Yichen Chen","email":"","orcid":"","institution":"Ningbo Institute of Medical Science","correspondingAuthor":false,"prefix":"","firstName":"Yichen","middleName":"","lastName":"Chen","suffix":""},{"id":286648265,"identity":"a2c50ccd-05ea-411e-9644-abd469c0101f","order_by":7,"name":"Weili Zhu","email":"","orcid":"","institution":"Jiaxing University Affiliated Maternity and Child Hospital","correspondingAuthor":false,"prefix":"","firstName":"Weili","middleName":"","lastName":"Zhu","suffix":""},{"id":286648266,"identity":"2111d7a7-5d0f-4e9c-98fa-25f686acaed2","order_by":8,"name":"Xiuhui Li","email":"","orcid":"","institution":"Jiaxing University Affiliated Maternity and Child Hospital","correspondingAuthor":false,"prefix":"","firstName":"Xiuhui","middleName":"","lastName":"Li","suffix":""},{"id":286648267,"identity":"199e5f84-b404-4b7f-a5e5-232f7ca9379d","order_by":9,"name":"Xuan Che","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA1UlEQVRIie2NPwuCQBiHXwl0uXB9IaqvoBxE4JdRhFy01oaGE8GxViGir2Ic3GR7g5vg1ODUKP1xabJrC7pneZbfww9AofhFsNMEIH96IJ/Q7xOPdZZIzH0iRmRTBse4mCGsHY8Z57z/pBQ+JaKOYiYWCEXgMbJ0exMLQ7siOo8S4AK1lHsMifUhWTWctDzQ4ZSi1koloVYNU+6S1wuTSPCyoPZhy+0MhD93RUBTEvYnZubXeL3x6TQr7EuzccY7o+hP3v5yAPdhXXL//GPyW4VCofgv7ixoQz2FsaiSAAAAAElFTkSuQmCC","orcid":"","institution":"Jiaxing University Affiliated Maternity and Child Hospital","correspondingAuthor":true,"prefix":"","firstName":"Xuan","middleName":"","lastName":"Che","suffix":""}],"badges":[],"createdAt":"2024-02-16 13:30:19","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-3961335/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-3961335/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s41598-024-84608-5","type":"published","date":"2025-03-22T15:57:55+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":79120480,"identity":"a5804e05-94ff-461b-81a9-4abdbd9bfd89","added_by":"auto","created_at":"2025-03-24 16:08:44","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":4969631,"visible":true,"origin":"","legend":"","description":"","filename":"wbzprhnxmhshfmtdkbcmhfxyzpnrnsnb.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3961335/v1_covered_ae450985-3627-4e5d-9d8b-55a3851e0f45.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Exosomal MiR-92a-3p serves as a Promising Diagnostic Marker and Potential Therapeutic Target for Adenomyosis","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"scientific-reports","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"scirep","sideBox":"Learn more about [Scientific Reports](http://www.nature.com/srep/)","snPcode":"","submissionUrl":"","title":"Scientific Reports","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Scientific Reports","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-3961335/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-3961335/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"This study aimed to elucidate the role of microRNA miR-92a-3p in the pathogenesis of adenomyosis. We focused on understanding how miR-92a-3p in exosomes derived from ectopic lesions influences the behavior of endometrial cells, DRG neurons, and Human Umbilical Vein Endothelial Cells (HUVECs), and its potential as a non-invasive diagnostic biomarker. Our findings revealed that MiR-92a-3p is significantly upregulated in exosomes derived from ectopic lesions of adenomyosis. This upregulation was associated with enhanced migration and invasion capabilities in eutopic endometrial cells, DRG neurons, and HUVECs. Furthermore, the study demonstrated a significant correlation between the levels of MiR-92a-3p in urinary exosomes and the clinical symptoms of adenomyosis, suggesting its potential as a non-invasive biomarker for the disease. This study elucidates an exosomal signaling process via miR-92a-3p that drives pathological infiltration and angiogenesis to promote adenomyosis progression. Upregulated miR-92a-3p in biofluid exosomes shows promising non-invasive biomarker potential for diagnosis and monitoring of this disease. Our findings unveil novel targets and tools for improved clinical management.Our research uncovers the significant role of miR-92a-3p in adenomyosis pathogenesis. We demonstrate that miR-92a-3p, upregulated in exosomes from ectopic lesions, enhances migration and invasion of endometrial cells, DRG neurons, and HUVECs. Crucially, miR-92a-3p levels in urinary exosomes correlate with adenomyosis symptoms, highlighting its potential as a non-invasive biomarker. This study offers new insights into adenomyosis progression and introduces novel diagnostic and therapeutic avenues.","manuscriptTitle":"Exosomal MiR-92a-3p serves as a Promising Diagnostic Marker and Potential Therapeutic Target for Adenomyosis","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-04-05 06:48:47","doi":"10.21203/rs.3.rs-3961335/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2024-07-24T04:43:19+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-05-03T23:25:27+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"1a98543d-99d1-46ae-a25b-da063115c9f6","date":"2024-04-22T22:11:17+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2024-04-22T19:12:55+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2024-04-22T19:02:33+00:00","index":"","fulltext":""},{"type":"editorInvited","content":"","date":"2024-04-02T12:59:54+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2024-04-02T12:51:22+00:00","index":"","fulltext":""},{"type":"submitted","content":"Scientific Reports","date":"2024-02-16T13:19:08+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"scientific-reports","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"scirep","sideBox":"Learn more about [Scientific Reports](http://www.nature.com/srep/)","snPcode":"","submissionUrl":"","title":"Scientific Reports","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Scientific Reports","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"b1812a3d-6419-41a4-8481-9c990cb0d09d","owner":[],"postedDate":"April 5th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":30171633,"name":"Biological sciences/Cell biology"},{"id":30171634,"name":"Health sciences/Biomarkers"},{"id":30171635,"name":"Health sciences/Diseases"},{"id":30171636,"name":"Health sciences/Pathogenesis"}],"tags":[],"updatedAt":"2025-03-24T16:02:39+00:00","versionOfRecord":{"articleIdentity":"rs-3961335","link":"https://doi.org/10.1038/s41598-024-84608-5","journal":{"identity":"scientific-reports","isVorOnly":false,"title":"Scientific Reports"},"publishedOn":"2025-03-22 15:57:55","publishedOnDateReadable":"March 22nd, 2025"},"versionCreatedAt":"2024-04-05 06:48:47","video":"","vorDoi":"10.1038/s41598-024-84608-5","vorDoiUrl":"https://doi.org/10.1038/s41598-024-84608-5","workflowStages":[]},"version":"v1","identity":"rs-3961335","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-3961335","identity":"rs-3961335","version":["v1"]},"buildId":"B-jG_2CBjPDmsCi4Wdhf-","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (19)

Source provenance

europepmc
last seen: 2026-06-13T06:41:28.371730+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK